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Abstract
Problem/Condition: Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both 
the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART 
includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related 
procedures). Women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth 
infants. Multiple births pose substantial risks to both mothers and infants, including obstetric complications, preterm delivery, and 
low birthweight infants. This report provides state-specific information for the United States (including the District of Columbia 
and Puerto Rico) on ART procedures performed in 2014 and compares birth outcomes that occurred in 2014 (resulting from 
ART procedures performed in 2013 and 2014) with outcomes for all infants born in the United States in 2014.
Period Covered: 2014.
Description of System: In 1996, CDC began collecting data on ART procedures performed in fertility clinics in the United 
States as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102–493). Data are 
collected through the National ART Surveillance System (NASS), a web-based data collection system developed by CDC. This 
report includes data from 52 reporting areas (the 50 states, the District of Columbia, and Puerto Rico).
Results: In 2014, a total of 169,568 ART procedures (range: 124 in Wyoming to 21,018 in California) with the intent to transfer 
at least one embryo were performed in 458 U.S. fertility clinics and reported to CDC. These procedures resulted in 56,028 
live-birth deliveries (range: 52 in Wyoming to 7,230 in California) and 68,782 infants born (range: 64 in Wyoming to 8,793 in 
California). Nationally, the total number of ART procedures performed per million women of reproductive age (15–44 years), a 
proxy measure of the ART usage rate, was 2,647 (range: 364 in Puerto Rico to 6,726 in Massachusetts). ART use exceeded the 
national average in 13 reporting areas (Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maryland, Massachusetts, 
New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Virginia). Eight reporting areas (Connecticut, the 
District of Columbia, Hawaii, Illinois, Maryland, Massachusetts, New Jersey, and New York) had rates of ART use exceeding 1.5 
times the national average.
Nationally, among ART transfer procedures in patients using fresh embryos from their own eggs, the average number of embryos 
transferred increased with increasing age of the woman (1.7 among women aged <35 years, 1.9 among women aged 35–37 years, 
and 2.3 among women aged >37 years). Among women aged <35 years, who typically are considered to be good candidates for 
elective single embryo transfer (eSET) procedures, the national eSET rate was 28.5% (range: 4.3% in Puerto Rico to 67.9% in 
Delaware).
In 2014, ART contributed to 1.6% of all infants born in the United States (range: 0.4% in Puerto Rico to 4.7% in Massachusetts) 
and 18.3% of all multiple-birth infants (range: 5.5% in Alaska and West Virginia to 37.3% in Hawaii), including 18.0% of all 
twin infants (range: 5.2% in some states to 36.2% in Hawaii) and 26.4% of all triplets and higher-order infants (range: 0% in 
some states to 65.2% in Hawaii). Percentages of live births that were multiple-birth deliveries were higher among infants conceived 
with ART (39.4%; range: 11.5% in Delaware to 55.6% in Puerto Rico) than among all infants born in the total birth population 
(3.5%; range: 2.2% in Puerto Rico to 4.4% in New Jersey). 
Approximately 38.0% of ART-conceived infants were twin 
infants, and 2.0% were triplets and higher-order infants. 
ART-conceived twins accounted for approximately 95.3% of 
all ART-conceived infants born in multiple deliveries.
Corresponding author: Saswati Sunderam, Division of Reproductive 
Health, National Center for Chronic Disease Prevention and 
Health Promotion, CDC. Telephone: 770-488-6356; E-mail: 
msunderam@cdc.gov.
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Introduction
Since the birth of the first U.S. infant conceived with 
assisted reproductive technology (ART) in 1981, use of 
advanced technologies to overcome infertility has increased, 
as has the number of fertility clinics providing ART services 
and procedures in the United States (1). In 1992, Congress 
passed the Fertility Clinic Success Rate and Certification Act 
(FCSRCA) (Public Law 102–493), which requires that all U.S. 
fertility clinics performing ART procedures report data to CDC 
annually on every ART procedure performed. CDC initiated 
data collection in 1996 and published the first annual ART 
Success Rates Report in 1997 (2). Several measures of success 
for ART are presented in the annual report (1,3), including 
the percentage of ART procedures and transfers that result in 
pregnancies, live-birth deliveries, singleton live-birth deliveries, 
and multiple live-birth deliveries.
Although ART helps millions of infertile couples to achieve 
pregnancy, it is associated with potential health risks to both 
mother and infant. Because multiple embryos are transferred 
in the majority of ART procedures, ART often results in 
multiple-gestation pregnancies and multiple births (4–11). 
Risks to the mother from multiple births include higher rates of 
caesarean deliveries, maternal hemorrhage, pregnancy-related 
hypertension, and gestational diabetes (12,13). Risks to the 
infant include prematurity, low birthweight, infant death, and 
elevated risk for birth defects and developmental disability 
(4–18). Further, even singleton infants conceived with ART 
have a higher risk for low birthweight and prematurity than 
singletons not conceived with ART (19,20).
Nationally, infants conceived with ART contributed to 5.5% of all low birthweight (<2,500 g) infants (range: 1.2% in West 
Virginia to 14.2% in Massachusetts). Among ART-conceived infants, 27.8% were low birthweight (range: 10.6% in Delaware to 
44.4% in Puerto Rico), compared with 8.0% among all infants (range: 5.9% in Alaska to 11.3% in Mississippi).
ART-conceived infants contributed to 4.7% of all preterm (<37 weeks) infants (range: 1.2% in Puerto Rico to 13.4% in 
Massachusetts). Percentages of preterm births were higher among infants conceived with ART (33.2%; range: 18.9% in the 
District of Columbia to 45.9% in Puerto Rico) than among all infants born in the total birth population (11.3%; range: 8.5% 
in California to 16.0% in Mississippi).
The percentage of ART-conceived infants who were low birthweight was 8.9% (range: 3.2% in some states to 16.1% in Vermont) 
among singletons and 55.2% (range: 38.5% in Delaware to 77.8% in Alaska) among twins; the corresponding percentages of low 
birthweight infants among all infants born were 6.3% for singletons (range: 4.6% in Alaska, North Dakota, and Oregon to 9.5% 
in Puerto Rico) and 55.2% for twins (range: 46.1% in Alaska to 65.6% in Mississippi).
The percentage of ART-conceived infants who were preterm was 13.2% (range: 7.5% in Rhode Island to 23.4% in West Virginia) 
among singletons and 62.2% (range: 33.3% in some states to 81.4% in Mississippi) among twins; the corresponding percentages 
of preterm infants among all infants were 9.7% for singletons (range: 1.7% in the District of Columbia to 14.2% in Mississippi) 
and 56.6% for twins (range: 47.2% in Vermont to 66.9% in Wyoming).
Interpretation: The percentage of infants conceived with ART varied considerably by reporting area. Multiple births from ART 
contributed to a substantial proportion of all twins, triplets, and higher-order infants born. Low birthweight and preterm infant 
birth rates were disproportionately higher among ART-conceived infants than among the overall birth population. Although women 
aged <35 years are typically considered good candidates for eSET, on average two embryos were transferred per ART procedure 
with women in this group. Compared with ART-conceived singletons, ART-conceived twins were approximately five times more 
likely to be born preterm and approximately six times more likely to be born with low birthweight. Singleton infants conceived 
with ART had higher percentages of preterm birth and low birthweight than all singleton infants born in the United States. ART 
use per population unit was geographically variable, with 13 reporting areas showing ART use higher than the national rate. Of 
the four states (Illinois, Massachusetts, New Jersey, and Rhode Island) with comprehensive statewide-mandated health insurance 
coverage for ART procedures (i.e., coverage for at least four cycles of IVF), three (Illinois, Massachusetts, and New Jersey) had 
rates of ART use exceeding 1.5 times the national rate. This type of mandated insurance has been associated with greater use of 
ART and likely accounts for some of the difference in per capita ART use observed among states.
Public Health Action: Reducing the number of embryos transferred and increasing use of eSET when clinically appropriate could 
help reduce multiple births and related adverse health consequences. Because twins account for the majority of ART-conceived 
multiple births, improved provider practices and patient education and counseling on the maternal and infant health risks of having 
twins are needed. Although ART contributes to high percentages of multiple births, other factors not investigated in this report 
(e.g., delayed childbearing and use of non-ART fertility treatments) also contribute to multiple births and warrant further study.
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This report was compiled on the basis of ART surveillance 
data reported to CDC’s Division of Reproductive Health 
for procedures performed in 2014. Data on the use of ART 
are presented for residents of each U.S. state, the District 
of Columbia, and Puerto Rico; data also are reported for 
outcomes for infants born in 2014 resulting from ART 
procedures performed in 2013 and 2014. The report also 
examines the contribution of ART to select outcomes (i.e., 
multiple-birth infants, low birthweight infants, and preterm 
infants) and compares ART infant outcomes with outcomes 
among all infants born in the United States (including Puerto 
Rico) in 2014.
Methods
National ART Surveillance System
In 1996, CDC initiated data collection of ART procedures 
performed in the United States. ART data for 1995–2003 were 
obtained from the Society for Assisted Reproductive Technology 
(SART). Since 2004, CDC has contracted with Westat, Inc., a 
statistical survey research organization, to obtain data from all 
fertility clinics in the United States through the National ART 
Surveillance System (NASS), a web-based data collection system 
developed by CDC (https://www.cdc.gov/art/nass/index.html). 
Clinics can enter their data directly into NASS and verify its 
accuracy before sending the data to Westat. SART-member 
clinics can report their data to NASS through SART. Non-SART-
member clinics can report their data directly through NASS. 
The data then are compiled by Westat and reviewed by both 
CDC and Westat. A small proportion of clinics (7.8%) did not 
report their data to CDC in 2014 and are listed as nonreporting 
programs in the 2014 ART Fertility Clinic Success Rates Report, 
as required by FCSRCA. Because nonreporting clinics tend to 
be smaller on average than reporting clinics, NASS is estimated 
to contain information on 98.0% of all ART procedures in the 
United States (1).
Data collected include patient demographics, medical history, 
and infertility diagnoses; clinical information pertaining to the 
ART procedure type; and information regarding resultant 
pregnancies and births. The data file contains one record per 
ART procedure (or cycle of treatment) performed. Because 
ART providers typically do not provide continued prenatal care 
after a pregnancy is established, information on live births for 
all procedures is collected by ART clinics either directly from 
the patients (73.7%) or from the patients’ obstetric providers 
(25.2%). Approximately 1.0% of pregnancy outcomes are 
missing in NASS.
ART Procedures
ART includes fertility treatments in which eggs or embryos 
are handled in a laboratory (e.g., in vitro fertilization [IVF], 
gamete intrafallopian transfer, and zygote intrafallopian 
transfer). Approximately 99.0% of ART procedures performed 
are IVF. Because an ART procedure consists of several steps 
over an interval of approximately 2 weeks, a procedure often 
is referred to as a cycle of treatment. An ART cycle usually 
begins with drug-induced ovarian stimulation. If eggs are 
produced, the cycle progresses to the egg-retrieval stage, which 
involves surgical removal of the eggs from the ovaries. After 
the eggs are retrieved, they are combined with sperm in the 
laboratory during the IVF procedure. If successful, the most 
viable embryos (i.e., those that appear morphologically most 
likely to develop and implant) are selected for transfer back 
into the uterus by clinicians. If an embryo implants in the 
uterus, a clinical pregnancy is diagnosed by the presence of 
a gestational sac detectable by ultrasound. The majority of 
pregnancy losses occur within the first 12 weeks. Beyond 12 
weeks of gestation, the pregnancy usually progresses to a live-
birth delivery, defined as the delivery of one or more live-born 
infants. Survival of pregnancy ranges from 95.0% at 16 weeks 
to 98.0% at 20 weeks (21). ART does not include treatments in 
which only sperm are handled (i.e., intrauterine insemination) 
or procedures in which a woman takes drugs to stimulate egg 
production without the intention of having eggs retrieved.
ART procedures are classified into four types on the basis of 
the source of the egg (patient or donor) and the status of the 
embryos (fresh or thawed). Both fresh and thawed embryos can 
be derived from either the patient’s eggs or the donor’s eggs. 
Both patient and donor embryos can be created using sperm 
from a partner or from a donor. ART procedures involving 
fresh embryos include an egg-retrieval stage. ART procedures 
that use thawed embryos do not include egg retrieval because 
the eggs were fertilized during a previous procedure and the 
resultant embryos were frozen until the current procedure. An 
ART cycle can be discontinued at any step for medical reasons 
or by patient choice.
Variables and Definitions
ART data and outcomes from ART procedures are presented 
by patient’s residence (i.e., reporting area) at the time of 
treatment, which might not be the same as the location 
where the procedure was performed. If information on 
patient’s residence was missing, residence was assigned as the 
location where the procedure was performed. ART procedures 
performed in the United States among non-U.S. residents are 
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included in NASS data; however, they were excluded from 
certain calculations for which the exact denominators were not 
known. To protect confidentiality in the presentation of data 
in tables, cells with values of 1–4 are suppressed, as are data 
that can be used to derive cell values of 1–4; however, these 
values are included in the totals. In some cases as applicable, 
states are not identified when reporting ranges to protect 
confidentiality. Because of small numbers, ART data from U.S. 
territories (with the exception of Puerto Rico) are not included 
in this report. In addition, estimates derived from cell values 
<20 in the denominator have been suppressed because they 
are unstable, and estimates could not be calculated when the 
denominator was zero (e.g., preterm birth among triplets, in 
reporting areas with no triplet births).
This report presents data on all procedures initiated with the 
intent to transfer at least one embryo; however, birth outcomes 
are determined on the basis of procedures that involved 
embryo transfer. The number of ART procedures performed 
per 1 million women of reproductive age (15–44 years) was 
calculated and the resulting rate approximates the proportion 
of women of reproductive age who used ART in each reporting 
area. However, this proxy measure of ART use is only an 
approximation because some women who used ART might fall 
outside the age range of 15–44 years (approximately 10.0% 
in 2014) and some women might have had more than one 
procedure during the reporting period.
A live-birth delivery was defined as birth of one or more 
live-born infants. A singleton live-birth delivery was defined 
as a birth of only one infant who was born live. A multiple 
live-birth delivery was defined as a birth of two or more 
infants, at least one of whom was born live. Low birthweight 
was defined as <2,500 g and very low birthweight as <1,500 g. 
For comparability with births to women who did not undergo 
ART, for whom gestational age is determined on the basis of 
the date of the last menstrual period, gestational age for fresh 
ART procedures was calculated by subtracting the date of egg 
retrieval from the birth date and adding 14 days. For frozen 
embryo cycles and for fresh ART procedures for which the date 
of retrieval was not available, gestational age was calculated by 
subtracting the date of embryo transfer from the birth date 
and adding 17 days (to account for an average of 3 days in 
embryo culture). Preterm delivery was defined as gestational 
age <37 weeks and very preterm delivery as gestational age 
<32 weeks (22).
Elective single-embryo transfer (eSET) is a procedure 
in which one embryo, selected from a larger number of 
available embryos, is placed in the uterus, with extra embryos 
cryopreserved. Fresh transfer procedures in which only one 
embryo was transferred but no embryos were cryopreserved are 
considered single-embryo transfer (SET) but not considered 
eSET. In this report, percentages of eSET procedures and the 
average number of embryos transferred were calculated for 
patients who used fresh embryos from their own eggs, in which 
at least one embryo was transferred. The rate of eSET was 
calculated by dividing the total number of transfer procedures, 
in which only one embryo was transferred and one or more 
embryos were cryopreserved, by the sum of the total number 
of single-embryo transfer procedures where extra embryos were 
cryopreserved plus the total number of transfer procedures 
in which more than one embryo was transferred. Transfer 
procedures in which only one embryo was transferred but no 
embryos were cryopreserved were excluded from the calculation 
of eSET percentages. The average number of embryos 
transferred for three age groups (<35 years, 35–37 years, and 
>37 years) was calculated by dividing the total number of 
embryos transferred by the total number of embryo-transfer 
procedures performed in that age group.
The contribution of ART to all infants born in a particular 
reporting area was used as a second measure of ART use. 
The contribution of ART to an outcome (e.g., preterm or 
low birthweight infant) was calculated by dividing the total 
number of outcomes among ART-conceived infants by the total 
number of outcomes among all infants born. The percentage of 
infants (ART conceived and all infants) born in the reporting 
area was calculated by plurality (singleton, multiple, twin, 
and triplet and higher-order birth) by dividing the number of 
infants (ART conceived and all infants) in each plurality group 
by the total number of infants born (ART conceived and all 
infants). The percentage of infants with low birthweight and 
preterm delivery was also calculated for each plurality group 
(singleton, twin, and triplet and higher-order births) for both 
ART-conceived infants and all infants by dividing the number 
of low birthweight or preterm infants in each plurality group 
by the total number of infants in that plurality group.
Content of This Report
This report provides information on U.S. ART procedures 
performed in 2014 and compares infant outcomes for 
ART-conceived infants born in 2014 (resulting from ART 
procedures performed in 2013 and 2014) with outcomes for 
all infants born in 2014 in the United States. Specifically, 
this report provides data on the number and outcomes of all 
ART procedures performed among patients residing in 52 
reporting areas (the 50 states, the District of Columbia, and 
Puerto Rico) in 2014. For each of these reporting areas, data 
are presented on the number of ART procedures and embryo 
transfers performed; the resulting number of pregnancies, 
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live-birth deliveries (overall, singleton, and multiple), and 
live-born infants; and the number of ART procedures in 
relation to the number of women in the reproductive age group 
(15–44 years) (23).* Data are also presented on the number of 
embryo-transfer procedures performed, the average number of 
embryos transferred, and the percentage of eSET procedures 
performed among women who used fresh embryos from their 
own eggs, by age group.
For each reporting area, the proportions of singletons and 
multiple-birth (including twin and triplet and higher-order) 
infants resulting from ART are compared with the respective 
proportions among all infants born in that location in 2014. 
Infants born in the reporting area during that year include 
those who were conceived naturally and those resulting from 
ART and other infertility treatments. To accurately assess the 
proportion of ART births among overall U.S. births in 2014, 
ART births were aggregated from two reporting years: 1) 
infants conceived with ART procedures performed in 2013 
and born in 2014 (69.0% of the live-birth deliveries reported 
to the ART surveillance system for 2014) and 2) infants 
conceived with ART procedures performed in 2014 and born 
in 2014 (31.0% of the live-birth deliveries reported to the ART 
surveillance system for 2014). Data on the total number of 
live-birth and multiple-birth infants in each reporting area in 
2014 were obtained from U.S. natality files (24). The report 
presents the number and percentage of select adverse perinatal 
outcomes (low birthweight, very low birthweight, preterm 
delivery, and very preterm delivery) among ART-conceived 
infants and all infants and the contribution of ART to these 
outcomes. The percentage of adverse perinatal outcomes is 
reported for singleton, twin, and triplet and higher-order 
infants for ART-conceived infants and all infants.
Results
Overview of Fertility Clinics
Of 498 fertility clinics in the United States that performed 
ART procedures in 2014, a total of 458 (92.2%) provided data 
to CDC, with the majority located in or near major cities in 
the United States. The number of fertility clinics performing 
ART procedures varied by reporting area. The reporting areas 
with the largest number of fertility clinics providing data for 
2014 were California (65), Texas (42), New York (36), Florida 
(28), and Illinois (26) (Figure 1).
Number and Type of ART Procedures
The number, type, and outcome of ART procedures 
performed in 2014 are provided according to patient’s residence 
for all 52 reporting areas (Table 1). Residency data are missing 
for approximately 0.6% of procedures performed and 0.7% of 
live-birth deliveries; however, they are included in the totals. 
Approximately 16.6% of ART procedures were conducted 
in reporting areas other than the patient’s state of residence. 
Non-U.S. residents accounted for approximately 2.7% of ART 
procedures, 3.1% of ART live-birth deliveries, and 3.1% of 
ART infants born.
In 2014, a total of 208,604 ART procedures were reported 
to CDC (1). This report includes data for 169,568 ART 
procedures performed in the United States (including Puerto 
Rico) with the intent to transfer at least one embryo (Table 1). 
It excludes 35,406 egg/embryo-freezing and embryo-banking 
procedures that did not result in an embryo transfer; 3,596 
oocyte-thaw procedures; and 34 procedures that were 
performed in the remaining territories. Of 169,568 procedures 
performed in the reporting areas, a total of 138,029 (81.4%) 
progressed to embryo transfer (Table 1). Of 138,029 ART 
procedures that progressed to the embryo-transfer stage, 
68,988 (50.0%) resulted in a pregnancy and 56,028 (40.6%) in 
a live-birth delivery. The 56,028 live-birth deliveries included 
43,544 singleton live-birth deliveries (77.7%) and 12,484 
multiple live-birth deliveries (22.3%) and resulted in 68,782 
live-born infants (Table 1) (Figure 2).
* Data regarding population size were compiled on the basis of July 1, 2014, 
estimates from the U.S. Census Bureau.
FIGURE 1. Location and number* of assisted reproductive technology 
clinics — United States and Puerto Rico, 2014
10–36
3–9
1–2
42–65
0
DC
PR
Abbreviations: DC = District of Columbia; PR = Puerto Rico.
* In 2014, of the 498 clinics in the United States, 458 (92.2%) submitted data.
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Six reporting areas with the largest number of ART 
procedures (California, Illinois, Massachusetts, New Jersey, 
New York, and Texas) accounted for 49.1% (83,325 of 
169,568) of all ART procedures, 48.6% (67,158 of 138,029) 
of all embryo-transfer procedures, 46.8% (32,207 of 68,782) 
of all infants born from ART, and 45.3% (5,652 of 12,484) 
of all ART multiple live-birth deliveries in the United States 
(Table 1); however, these six reporting areas accounted for only 
36.7% of all U.S. births (24).
The number of ART procedures per 1 million women of 
reproductive age (15–44 years) varied from 364 in Puerto 
Rico to 6,726 in Massachusetts, with an overall national rate 
of 2,647. Thirteen reporting areas (Connecticut, Delaware, 
Hawaii, Illinois, Maryland, Massachusetts, New Hampshire, 
New Jersey, New York, Pennsylvania, Rhode Island, Virginia, 
and the District of Columbia) had rates higher than the 
national rate. Of these reporting areas, Massachusetts (6,726) 
and the District of Columbia (6,662) had rates exceeding twice 
the national rate, while Connecticut (5,195), Hawaii (4,180), 
Illinois (4,110), Maryland (4,651), New Jersey (5,143) and 
New York (5,145) had rates exceeding 1.5 times the national 
rate (Table 1) (Figure 3).
Embryo Transfer and Patient’s Age
The number of embryo-transfer procedures performed, 
the average number of embryos transferred per procedure, 
and the percentage of eSET procedures performed among 
women who used fresh embryos from their own eggs are 
provided by reporting area and age group (Table 2). Overall, 
the number of embryo-transfer procedures performed was 
30,887 among women aged <35 years, 14,647 among women 
aged 35–37 years, and 21,504 among women aged >37 years. 
Nationally, the average number of embryos transferred per 
procedure was 1.7 among women aged <35 years (range: 1.3 
in Delaware to 2.1 in Puerto Rico), 1.9 among women aged 
35–37 years (range: 1.5 in Maine to 2.3 in Hawaii), and 2.3 
among women aged >37 years (range: 1.9 in Nevada to 3.0 in 
Montana). Nationally, percentage of eSET was 28.5% among 
women aged <35 years (range: 4.3% in Puerto Rico to 67.9% 
in Delaware), 16.7% among women aged 35–37 years (range: 
0% in South Dakota to 39.5% in Maine), and 4.7% among 
women aged >37 years (range: 0% in 9 reporting areas to 
12.5% in Delaware and Idaho). Among women aged <35 years, 
eSET percentage exceeded 1.5 times the national rate in six 
reporting areas (Delaware, the District of Columbia, Maine, 
Massachusetts, Maryland, and New Hampshire).
FIGURE 2. Number of outcomes of assisted reproductive technology procedures, by type of outcome — United States and Puerto Rico, 2014
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Singleton and Multiple-Birth Infants
Among 4,022,510 infants born in the United States and 
Puerto Rico in 2014 (21), a total of 65,296 (1.6%) were 
conceived with ART procedures performed in 2013 and 2014 
(Table 3). California, Texas, and New York had the highest total 
number of all infants born (502,879, 399,766, and 238,773, 
respectively), as well as ART-conceived infants born (8,528, 
5,268, and 6,492, respectively). The contribution of ART to 
all infants born was highest in Massachusetts (4.7%), followed 
by the District of Columbia (3.8%), New Jersey (3.7%), and 
Connecticut (3.6%). Although singletons accounted for 96.5% 
of all infants born in 2014 (range: 95.6% in New Jersey to 
97.8% in Puerto Rico), singletons accounted for only 60.6% 
of all ART-conceived infants (range: 44.4% in Puerto Rico to 
88.5% in Delaware).
Nationwide, 39.4% of ART-conceived infants were born in 
multiple-birth deliveries (range: 11.5% in Delaware to 55.6% 
in Puerto Rico), compared with only 3.5% of all infants (range: 
2.2% in Puerto Rico to 4.4% in New Jersey) (Table 4). ART-
conceived twins accounted for approximately 95.3% (24,514 
of 25,714) of all ART-conceived infants born in multiple 
deliveries. ART multiple-birth infants contributed to 18.3% 
of all multiple-birth infants (range: 5.5% in Alaska and West 
Virginia to 37.3% in Hawaii). Approximately 37.5% of all 
ART-conceived infants were twins (range: 11.5% in Delaware 
to 51.1% in Puerto Rico), compared with 3.4% of all infants 
(range: 2.2% in New Mexico and Puerto Rico to 4.2% in 
Connecticut, Massachusetts, and New Jersey). ART-conceived 
twin infants contributed to 18.0% of all twins born in 2014 
(range: 5.2% in some states to 36.2% in Hawaii). Finally, 
1.8% of ART-conceived infants were triplets and higher-order 
multiples (range: 0% in Alaska, Delaware, and Montana to 
5.6% in some states), compared with 0.1%–0.2% of all infants. 
ART triplet and higher-order infants contributed to 26.4% of 
all triplet and higher-order infants born in 2014 (range: 0% in 
Alaska, Delaware, and Montana to 65.2% in Hawaii).
Adverse Perinatal Outcomes
Nationally, ART-conceived infants contributed to 
approximately 5.5% of all low birthweight infants (range: 
1.2% in West Virginia to 14.2% in Massachusetts) and 5.6% 
of all very low birthweight infants (range: 0.9% in some 
states to 14.0% in Hawaii) (Table 5). In four reporting areas 
(Connecticut, Hawaii, Massachusetts, and New Jersey), >10% 
of all low birthweight and all very low birthweight infants 
born were conceived with ART. In all reporting areas, the 
FIGURE 3. Number of reporting areas by number of assisted reproductive technology procedures performed among women of reproductive 
age (15–44 years)* — United States and Puerto Rico, 2014 
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percentage of low birthweight and very low birthweight infants 
was higher among infants conceived with ART than among 
all infants. Among ART-conceived infants, 27.8% had low 
birthweight (range: 10.6% in Delaware to 44.4% in Puerto 
Rico), compared with 8.0% among all infants (range: 5.9% 
in Alaska to 11.3% in Mississippi). Approximately 4.9% of 
ART-conceived infants had very low birthweight (range: 0.9% 
in some states to 9.6% in Louisiana), compared with 1.4% 
among all infants (range: 0.9% in Alaska to 2.1% in the District 
of Columbia and Mississippi).
Nationally, ART contributed to approximately 4.7% (range: 
1.2% in Puerto Rico to 13.4% in Massachusetts) and 5.0% 
(range: 1.1% in Puerto Rico to 14.7% in Massachusetts) of 
all preterm and very preterm infants, respectively (Table 6). In 
three reporting areas (Connecticut, Massachusetts, and New 
Jersey), >10% of all preterm and very preterm infants were 
conceived with ART. As with low birthweight, the percentage 
of preterm and very preterm infants was higher among ART-
conceived infants than among the total birth population. 
Among ART-conceived infants, 33.2% were born preterm 
(range: 18.9% in the District of Columbia to 45.9% in Puerto 
Rico), compared with 11.3% among all infants (range: 8.5% 
in California to 16.0% in Mississippi). Approximately 5.9% of 
ART-conceived infants were very preterm (range: 2.2% in the 
District of Columbia to 12.0% in North Dakota), compared 
with 1.9% among all infants (range: 1.3% in California, Idaho, 
and Utah to 2.9% in Alabama).
The percentage of ART-conceived infants who were low 
birthweight was 8.9% (range: 3.2% in some states to 16.1% 
in Vermont) among singletons, 55.2% (range: 38.5% in 
Delaware to 77.8% in Alaska) among twins, and 95.3% 
(range: 0% in some states to 100% in several reporting areas) 
among triplets and higher-order infants; the corresponding 
percentage among all infants born was 6.3% (range: 4.6% in 
Alaska, North Dakota, and Oregon to 9.5% in Puerto Rico) 
among singletons, 55.2% (range: 46.1% in Alaska to 65.6% 
in Mississippi) among twins, and 94.5% (range: 88.4% in 
Alabama to 100% in several reporting areas) among triplets 
and higher-order infants (Table 7).
The percentage of ART-conceived infants who were born 
preterm was 13.2% among singletons (range: 7.5% in Rhode 
Island to 23.4% in West Virginia), 62.2% among twins (range: 
33.3% in some states to 81.4% in Mississippi), and 98.2% among 
triplets and higher-order infants (range: 50.0% in some states to 
100% in several reporting areas); the corresponding percentage 
among all infants was 9.7% for singletons (range: 1.7% in the 
District of Columbia to 14.2% in Mississippi), 56.6% for twins 
(range: 47.2% in Vermont to 66.9% in Wyoming), and 93.8% 
for triplets and higher-order infants (range: 52.2% in Hawaii to 
100% in several reporting areas) (Table 8).
Discussion
Overview
The use of ART has increased substantially in the United 
States since the beginning of ART surveillance. In 1996 (the 
first full year for which ART data were reported to CDC), a 
total of 20,597 infants were born from 64,036 ART procedures 
(25). Since then, the number of procedures reported to CDC 
and the number of infants born from ART procedures have 
approximately tripled. Several changes can be observed in 
ART use and outcomes since the preceding reporting year in 
2013 (26). The rate of ART use as measured by procedures 
performed per 1 million women of reproductive age 
(15–44 years) increased from 2,521 to 2,647. Among women 
aged <35 years, the average number of embryos transferred 
decreased (from 1.8 to 1.7) and correspondingly, the percentage 
of eSET increased (from 21.4% to 28.5%). Overall, the 
percentage of ART-conceived infants born in multiple-birth 
deliveries decreased from 41.1% to 39.4%, the percentage of 
ART-conceived twin infants decreased from 39.2% to 37.5%, 
and the percentage of ART-conceived triplets and higher-
order infants decreased from 1.9% to 1.8%. However, the 
contribution of ART-conceived twin infants to all twin infants 
and the contribution of ART-conceived preterm infants to all 
preterm infants remained unchanged at approximately 18.0% 
and 4.7%, respectively.
The contribution of ART on rates of multiple births and poor 
birth outcomes remained substantial in 2014, as approximately 
39.0% of ART-conceived infants were born in multiple births 
(compared with only 3.5% of infants among the total birth 
population). The contribution of ART-conceived infants to 
all triplets and higher-order infants increased slightly from 
25.2% in 2013 to 26.4% in 2014. ART-conceived twins 
accounted for approximately 95.3% (24,514 of 25,714) of all 
ART-conceived infants born in multiple-birth deliveries. On 
average, approximately two embryos were transferred among 
women aged <35 years, even though single embryo transfers 
have been associated with better perinatal outcomes among 
the majority of women in this age group (27,28). Although the 
rate of eSET procedures was still relatively low among women 
aged <35 years, from 2013 to 2014, the eSET rate increased 
from 21.4% to 28.5%. This is the largest annual percentage 
increase (33.6%) in eSET rate in the U.S ever detected through 
NASS. The percentage of low birthweight and preterm birth 
was substantially higher among ART-conceived infants (27.8% 
and 33.2%, respectively) than among all infants (8.0% and 
11.3%, respectively). Among ART-conceived infants, twins and 
triplets and higher-order infants were more likely than singletons 
to be born preterm (more than 4.5 times and seven times, 
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respectively). Although infants conceived with ART accounted 
for approximately 1.6% of total births in the United States in 
2014, the proportions of twins and triplets and higher-order 
infants attributable to ART were 18.0% and 26.4%, respectively.
Comparable data on ART use and embryo transfer practices 
from 17 European countries indicate that in 2011, ART use as 
defined by the number of procedures performed per 1 million 
women of reproductive age was 6,556; this was approximately 
2.7 times higher than the rate in the United States in 2011 
(29,30). Percentages of single-embryo transfers (eSET rates 
are not reported) varied widely in Europe, and a few countries 
reported a single-embryo transfer rate of over 50.0%. Overall, 
in these 17 reporting countries, approximately 81.0% of all 
IVF deliveries were singleton deliveries, compared with 72.0% 
in the United States (29,30).
Variations by Reporting Area
ART use (as measured by the number of ART procedures 
performed per 1 million women of reproductive age) varied 
widely by reporting area: residents of Connecticut, Delaware, 
Hawaii, Illinois, Maryland, Massachusetts, New Hampshire, 
New Jersey, New York, Pennsylvania, Rhode Island, Virginia, 
and the District of Columbia had higher ART use than the 
national level. Although some women who used ART might 
have been aged >44 years, this measure is still useful as a proxy 
indicator of ART use in each reporting area. Importantly, 
residents of California, Illinois, Massachusetts, New Jersey, 
New York, and Texas accounted for nearly half (47.0%) 
of all ART-conceived infants. The large number of ART 
procedures performed in these states is a result of the large 
size of the general population (California, Texas), higher ART 
use (Massachusetts, New Jersey), or both (New York, Illinois). 
The contribution of ART to all infants born was 4.7% in 
Massachusetts and 1.7% in California.
Such differences might be explained in part by variations in 
state health insurance coverage. A total of 15 states (Arkansas, 
California, Connecticut, Hawaii, Illinois, Louisiana, Maryland, 
Massachusetts, Montana, New Jersey, New York, Ohio, Rhode 
Island, Texas, and West Virginia) have passed legislation 
mandating insurance coverage for fertility treatments, although 
not all mandates require coverage for ART; mandates from 
four of these states (Illinois, Massachusetts, New Jersey, and 
Rhode Island) include comprehensive coverage for at least four 
cycles of IVF.† Three of the four states with comprehensive 
mandates (Illinois, Massachusetts, and New Jersey) had rates 
of ART use that were at least 50.0% higher than the national 
level. This type of mandated insurance has been associated 
with greater use of ART (31–33). Linkage of NASS data with 
birth certificate data in three states indicated that Massachusetts 
had a higher overall rate of ART use compared with Florida 
and Michigan, which do not have a comprehensive coverage 
mandate for ART (33).
Elective Single-Embryo Transfer Rates
According to the American Society of Reproductive 
Medicine (ASRM) and SART, eSET is recommended for 
favorable prognosis patients (patients who underwent their 
first IVF cycle and had extra embryos cryopreserved, patients 
with previous successful IVF procedures, or patients who are 
recipients of oocytes from a donor aged <35 years) (34). The 
guidelines issued by ASRM/SART on the number of embryos 
transferred have been revised several times (35–39). However, 
ASRM/SART guidelines on the number of embryos transferred 
allow for up to two embryos to be transferred even among 
favorable prognosis patients with patient counseling regarding 
risks for multifetal pregnancies (35). A high number of double-
embryo transfers occur among patients who might otherwise 
appear to be good candidates for transferring one embryo (40). 
Reducing the number of embryos transferred from two to one 
among those patients who have a good chance of pregnancy 
and live birth with single-embryo transfers will lower ART-
conceived twin rates (40,41).
Among women aged <35 years, the percentage of eSET 
procedures was higher (28.5% nationally) than among older 
age groups (16.7% among women aged 35–37 years and 4.7% 
among women aged >37 years nationally) and varied widely 
among reporting areas (range: 4.3% to 67.9%). The national 
percentage of eSET increased from 7.4% in 2009 to 28.5% 
in 2014 among women aged <35 years (26). From 2013 to 
2014, the national percentage of eSET among women aged 
<35 years increased by approximately 33.0%. The percentage 
of eSET is still lower in the United States than in countries 
that impose restrictions on the number of embryos transferred 
and provide extensive public funding for ART services (42). 
The eSET rates are influenced by many factors (e.g., patient’s 
age, diagnostic factors, and treatment costs); ART treatment 
costs are high and typically paid out-of-pocket by the patient. 
In the United States, even where mandated, coverage for 
infertility treatment can vary in scope (31). In the four states 
with mandatory comprehensive insurance coverage for ART, 
the eSET percentage among women aged <35 years was higher 
than the national average (28.5%) in Massachusetts (51.5%), 
New Jersey (34.7%), and Rhode Island (34.5%) but lower in 
† Eight states (Arkansas, Connecticut, Hawaii, Illinois, Maryland, Massachusetts, 
New Jersey, and Rhode Island) have insurance mandates that cover at least one 
ART cycle. Seven states (California, Louisiana, Montana, New York, Ohio, 
Texas, and West Virginia) have insurance mandates that exclude IVF coverage. 
Information is available at http://www.resolve.org/family-building-options/
insurance_coverage/state-coverage.html.
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Illinois (27.2%). Because ART procedures are expensive (out-
of-pocket costs to achieve a live birth estimated at $27,000 for 
patients with no insurance), broad insurance mandates for IVF 
might increase the use of eSET and decrease multiple-embryo 
transfer procedures (32,43,44). Wider acceptance and use of 
eSET procedures still face considerable barriers in the United 
States and might require strengthening the guidelines on 
embryo transfer practices along with expansion of insurance 
coverage for ART services (40,41,44,45).
ART Multiple-Birth Infants
Singleton live-birth deliveries have lower risks than multiple-
birth deliveries for adverse birth outcomes such as prematurity, 
low birthweight, disability, and death (46–48). To optimize 
healthy birth outcomes, the transfer of fewer embryos should 
be encouraged, where appropriate, taking into consideration 
the patient’s age and prognosis (27). The percentage of ART-
conceived multiple-birth infants in the United States decreased 
from 53.1% in 2000 to 39.4% in 2014 (49). A substantial 
decrease was noted in the percentage of ART-conceived triplets 
and higher-order infants (from 8.9% in 2000 to 1.8% in 
2014), and a smaller decrease was noted in the percentage of 
ART-conceived twins (from 44.2% in 2000 to 37.5% in 2014).
In the past, the slow decrease in twin-infant birth rates 
among women who undergo ART procedures was largely 
attributable to gradual increases in eSET rates (40,41). From 
2013 to 2014, an historically large increase of 33.0% in 
national eSET rate was observed. Despite this increase in 
eSET use, ART-conceived twin infants still accounted for 
approximately 40.0% of all ART-conceived infants in 2014, 
and on average, 1.7 embryos were transferred among favorable 
prognosis patients aged <35 years. In addition to embryo 
transfer practices, high ART-conceived twin rates also might be 
partially explained by a desire for more than one child among 
couples experiencing infertility who might believe that the 
benefits of a multiple-gestation pregnancy outweigh the risks 
(50–52). Therefore, understanding the perspective of couples 
undergoing infertility treatments regarding multiple-gestation 
pregnancies and multiple births is an important consideration. 
Although a major barrier to the greater use of eSET might be 
the high out-of-pocket cost of ART, the use and acceptance 
of eSET among younger patients with good prognosis can 
be promoted through patient education. The findings in this 
report indicate that ART-conceived twins and higher-order 
infants were more than 4.5 times and seven times more likely, 
respectively, to be born preterm than were ART-conceived 
singletons. Studies indicate that patient education focusing 
on maternal and perinatal morbidity and mortality, as well 
as the economic costs of twin gestation, has been effective in 
reducing the preference for twins among patients (53–55).
The economic costs of multiple births also underscore the 
importance of efforts to reduce ART-related multiple births. 
In 2013, the mean health care cost to patients and insurers 
was estimated to be $26,922 for ART-conceived singleton 
deliveries, $115,238 for ART-conceived twins, and $434,668 
for ART-conceived triplets and higher-order infants (56). 
Transferring two embryos is associated with a slight increase 
in birth rate but a greater increase in the twin birth rate as 
compared with transferring a single embryo (27,57). However, 
transferring two embryos sequentially (single-embryo transfer 
over two sequential procedures) has similar cumulative live-
birth rates and lower twin delivery rates than transferring two 
embryos in a single procedure and might be a cost-effective 
transfer approach (58–60). As a result of the data on the 
higher economic costs of maternal and neonatal complications 
that occur with multiple births, insurance companies could 
consider expanded coverage for ART services that also includes 
clinically appropriate use of eSET and other limitations placed 
on the number of embryos transferred (41,45,56). Evidence 
from other countries suggests that greater insurance coverage 
for ART when combined with restrictions on the number of 
embryos transferred per cycle can reduce multiple births (45).
ART Low Birthweight Infants and 
Preterm Births
The percentage of low birthweight and very low birthweight 
infants was higher among ART-conceived infants than among 
infants in the total birth population. Three states (Connecticut, 
Massachusetts, and New Jersey) that had large numbers of ART 
procedures and births also had high ART contribution (>10%) 
to both categories of low birthweight and preterm births. 
In the United States, the contribution of ART to preterm 
births, the majority of which are also low birthweight, is a 
key concern. Fertility treatments, both ART and controlled 
ovarian stimulations, contribute substantially to preterm 
births (47,61). Preterm births are a leading cause of infant 
mortality and morbidity; preterm infants are at increased risk 
for death and have more health and developmental problems 
than full-term infants (47,62–64). The health risks associated 
with preterm birth have contributed to increased health care 
costs. The societal economic costs associated with all preterm 
births in the United States was last reported in 2005 and was 
estimated at $26 billion annually ($51,600 per infant born 
preterm) (47). In 2012, the societal economic costs associated 
with ART-conceived preterm infants in the United States was 
estimated at approximately $1.3 billion (65).
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In addition to the known multiple-birth risks associated with 
ART, even singleton infants conceived from ART procedures 
are at increased risk for low birthweight and preterm delivery. 
In 2014, of all ART-conceived singleton infants, 9.0% were 
low birthweight, compared with 6.3% of infants in the total 
birth population. The percentage of ART-conceived singletons 
born preterm was 13.2%, compared with 9.7% of infants 
in the total U.S. birth population. Therefore, adverse infant 
health outcomes (e.g., low birthweight and preterm delivery) 
among singletons also should be considered when assessing 
the effects of ART.
Limitations
The findings in this report are subject to at least five 
limitations. First, ART surveillance data were reported for 
each ART procedure performed rather than for each patient 
who used ART. Second, because patients can achieve a 
successful pregnancy after undergoing multiple procedures, the 
procedure-specific success rates reported here underestimate 
the true per-patient success rates. Third, prematurity and low 
birthweight could be associated with factors contributing to 
underlying infertility and not entirely to ART procedures. 
Fourth, approximately 8.0% of fertility clinics that performed 
ART in 2014 did not report their data to CDC, and these 
clinics might have had results differing from reporting 
clinics. Finally, NASS lacks data on embryo quality, which 
influences the use of eSET among favorable prognosis patients 
aged <35 years; however, having extra embryos available for 
cryopreservation has been shown to be a good predictor of 
embryo quality.
Conclusion
Since 1996, the number of ART procedures performed in 
the United States and the number of infants born as a result 
of these procedures nearly tripled. With this increasing use, 
ART-conceived infants represented 1.6% of infants born 
in the United States in 2014 and noticeably contributed to 
the prevalence of low birthweight and preterm deliveries, 
as approximately two fifths of ART-conceived infants were 
multiple-birth deliveries. Furthermore, among ART-conceived 
infants, although the percentage of triplets or higher-order 
infants has decreased since 2000, the percentage of twin infants 
has remained persistently high. Therefore, the impact of ART 
on poor birth outcomes remains substantial. This report 
documents the rates and contribution of ART to multiple-
birth deliveries, low birthweight, and preterm birth by patient’s 
reporting area of residence. It also highlights the differences 
in rates of low birthweight and prematurity between ART-
conceived infants and all infants in the total birth population. 
These findings allow state health departments to monitor 
the extent of ART-related adverse perinatal outcomes among 
singletons, twins, and triplets and higher-order infants in their 
reporting areas.
Comprehensive insurance coverage of ART can help increase 
access to fertility treatments (45). Increased use of ART in 
reporting areas with insurance mandates also can result in 
higher numbers of ART-conceived multiple-birth deliveries. 
The findings in this report indicate that ART use was higher 
than the national rate in all four states with mandated 
comprehensive insurance coverage. Three of these four states 
had use rates exceeding 1.5 times the national rate and among 
these three states, two had a percentage of multiple births that 
was lower than the national average. Further, in three of these 
states, among patients aged <35 years, the average number 
of embryos transferred was less than the national rate and 
the rate of eSET was higher than the national rate. Further 
research is needed to ascertain the influence of state health 
insurance mandates on ART use, embryo transfer practices, 
infant outcomes, and economic and out-of-pocket patient 
costs of multiple births (28,34,40,41). Addressing the risk 
for multiple-birth deliveries also requires understanding the 
perspectives of couples undergoing infertility treatments who 
might view a multiple birth, especially twins, as an acceptable 
or desired outcome or might lack awareness of the increased 
risks associated with multiple births to mothers and infants. 
Although the majority of clinicians acknowledge that the birth 
of a healthy singleton is the best outcome of ART, they might 
be sensitive to patient perspectives (34,35). Clinicians need to 
be aware of ongoing efforts to limit the number of embryos 
transferred to reduce the rate of multiple births, particularly 
twins, and encourage wider implementation of eSET, when 
clinically appropriate, as mechanisms of promoting singleton 
infant births among ART-conceived pregnancies (27,34,41).
CDC has outlined a public health oriented strategy for 
detection, prevention, and management of infertility, including 
improving ART practice and outcomes, through coordinated 
efforts of government and nongovernment organizations. The 
effort involves federal, state, and local agencies; the scientific 
community; health care professionals; insurance providers; 
employers; industry; nonprofit organizations; and organizations 
representing people coping with infertility (66). Of public 
health importance is the role of infertility treatment on adverse 
birth outcomes, primarily because of higher rates of multiple 
births. ART only partially explains the overall prevalence of 
these adverse outcomes in the United States. Other factors 
influencing multiple births include maternal age at conception 
and non-ART fertility treatments (47,61,67). The older age 
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of women giving birth accounted for a substantial increase in 
twins during 1980–2009 (67). The risk for multiple gestations 
associated with non-ART fertility treatments (i.e., controlled 
ovarian stimulation such as superovulation-intrauterine 
insemination and conventional ovulation induction) is less 
well-documented than those from ART procedures, as clinics 
are only mandated to report data on ART use. Further efforts 
also are needed to monitor the use of non-ART fertility 
treatments and their role in the increasing number of multiple-
birth deliveries (47,61). In 2011, approximately 19.0% of twin 
births in the United States were attributable to non-IVF fertility 
treatments (61). Multiple gestations resulting from non-ART 
fertility treatments also might contribute to preterm births 
(47,61). Additional research is needed to identify the causes and 
consequences of preterm births that occur because of infertility 
treatments and to develop and institute guidelines to reduce the 
number of multiple gestations (47,61). However, studies have 
demonstrated that singleton infants conceived with ovulation 
stimulation are more likely than naturally conceived infants 
to be small for gestational age (68). CDC is monitoring the 
prevalence of non-ART fertility treatment use and resultant 
outcomes among women who had live births in several states 
participating in the Pregnancy Risk Assessment Monitoring 
System (69). U.S. birth certificate data published annually by 
CDC’s National Center for Health Statistics plans to include 
information on the use of ART and non-ART treatments and 
birth outcomes from data year 2016. CDC also is working to 
improve state-based surveillance of ART, infertility, and other 
birth-related issues by linking data from NASS to data collected 
by states (i.e., birth certificate, infant death, hospital discharge, 
and birth defect registry information). This initiative, the States 
Monitoring Assisted Reproductive Technology (SMART) 
Collaborative,§ has been determined to be feasible and useful 
for monitoring long-term outcomes of ART (70,71). CDC 
will continue to provide updates of ART use in the United 
States as data become available.
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TABLE 1. Number* and outcomes of assisted reproductive technology procedures, by female patient’s reporting area of residence† at time of 
treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
No. of ART 
clinics§
No. of ART 
procedures 
performed
No. of ART 
embryo transfer 
procedures¶
No. of ART 
pregnancies
No. of ART 
live-birth 
deliveries
No. of ART 
singleton 
live-birth 
deliveries
No. of ART 
multiple 
live-birth 
deliveries
No. of ART 
live-born infants
ART procedures 
per 1 million 
women aged 
15–44 yrs**
Alabama 6 1,060 849 431 361 262 99 462 1,102.9
Alaska 1 198 176 80 67 50 17 86 1,344.1
Arizona 11 2,116 1,808 972 794 605 189 993 1,617.7
Arkansas 1 457 388 187 165 118 47 212 795.1
California†† 65 21,018 17,429 8,972 7,230 5,700 1,530 8,793 2,607.2
Colorado 8 1,889 1,578 1,048 856 683 173 1,031 1,741.6
Connecticut 9 3,554 2,680 1,316 1,077 849 228 1,311 5,194.7
Delaware 2 646 520 283 239 220 19 260 3,580.9
District of Columbia 3 1,183 932 398 316 280 36 353 6,662.2
Florida 28 7,559 6,191 2,950 2,374 1,770 604 3,002 2,050.1
Georgia†† 8 3,640 3,065 1,579 1,293 1,022 271 1,574 1,729.6
Hawaii†† 5 1,119 847 486 407 291 116 527 4,179.9
Idaho 1 455 397 218 177 104 73 250 1,445.1
Illinois 26 10,671 8,476 4,096 3,317 2,542 775 4,098 4,109.8
Indiana 10 1,950 1,632 790 634 442 192 832 1,505.3
Iowa 2 1,217 1,007 634 512 394 118 630 2,078.1
Kansas 4 1,013 762 386 327 244 83 415 1,807.9
Kentucky 5 1,177 1,038 480 378 259 119 497 1,378.9
Louisiana 5 1,248 965 492 418 309 109 532 1,323.9
Maine 1 382 337 148 111 91 20 130 1,633.7
Maryland 7 5,590 4,519 2,200 1,720 1,481 239 1,965 4,650.9
Massachusetts 8 9,209 7,904 3,618 2,927 2,446 481 3,414 6,725.8
Michigan 12 3,616 3,006 1,454 1,164 851 313 1,484 1,915.5
Minnesota 4 2,012 1,775 993 853 663 190 1,045 1,910.1
Mississippi 3 593 482 229 194 134 60 254 986.3
Missouri 8 2,111 1,811 881 712 549 163 881 1,794.8
Montana 1 258 207 123 101 76 25 125 1,389.6
Nebraska 2 786 621 353 303 208 95 401 2,158.9
Nevada 5 1,246 957 544 449 341 108 560 2,200.4
New Hampshire 1 735 620 285 245 197 48 294 3,016.9
New Jersey 19 8,863 6,914 3,735 3,068 2,430 638 3,708 5,143.3
New Mexico 1 280 242 123 107 88 19 127 704.3
New York 36 20,814 16,212 6,982 5,447 4,349 1,098 6,558 5,144.6
North Carolina 12 3,693 2,903 1,542 1,261 968 293 1,556 1,862.4
North Dakota 1 311 252 128 99 76 23 123 2,157.8
Ohio 12 3,732 3,226 1,577 1,313 949 364 1,687 1,687.5
Oklahoma 3 815 696 351 309 206 103 415 1,068.6
Oregon 4 1,304 1,118 683 597 413 184 787 1,680.2
Pennsylvania 18 6,521 5,282 2,532 2,004 1,624 380 2,389 2,709.1
Puerto Rico 3 260 230 103 77 51 26 104 363.7
Rhode Island 1 701 599 266 210 165 45 256 3,336.3
South Carolina 5 1,394 1,175 589 483 361 122 608 1,477.5
South Dakota 1 266 217 95 78 62 16 96 1,684.7
Tennessee 9 1,525 1,264 660 568 416 152 724 1,177.0
Texas 42 12,750 10,223 5,406 4,471 3,341 1,130 5,636 2,254.8
Utah 3 1,492 1,309 809 668 471 197 870 2,333.5
Vermont 2 210 176 79 64 52 12 76 1,810.6
Virginia 13 5,904 4,781 2,238 1,795 1,493 302 2,103 3,505.7
Washington 12 3,261 2,620 1,414 1,161 946 215 1,381 2,331.8
West Virginia 3 298 259 128 107 82 25 134 885.0
Wisconsin 7 1,759 1,473 759 650 489 161 819 1,617.8
Wyoming 0 124 107 62 52 41 11 64 1,118.9
Nonresident NA 4,583 3,772 2,101 1,718 1,290 428 2,150 —§§
Total 458 169,568 138,029 68,988 56,028 43,544 12,484 68,782 2,646.5
Abbreviations: ART = assisted reproductive technology; NA = not applicable.
 * Excludes 35,406 egg/embryo-freezing and embryo-banking procedures, 3,596 oocyte thaw procedures, and 34 procedures performed in territories not included in this report.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 § The ART procedures and outcomes by patient’s reporting area of residence do not necessarily reflect the procedures and outcomes of the ART clinics within the reporting area, as some 
patients seek treatment at a clinic in a location other than their area of residence.
 ¶ Embryo transfer procedures include all procedures performed in which an attempt was made to transfer at least one embryo.
 ** On the basis of U.S. Census Bureau estimates (23).
 †† In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency information was missing for 
963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
 §§ Non-U.S. residents excluded from rate because the appropriate denominators were not available.
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TABLE 2. Number of assisted reproductive technology embryo transfer procedures* among patients who used fresh embryos from their own 
eggs, by female patient’s age group and reporting area of residence† at time of treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
<35 yrs 35–37 yrs >37 yrs
No. of embryo 
transfer 
procedures
Average no. of 
embryos 
transferred eSET§ (%)
No. of embryo 
transfer 
procedures
Average no. of 
embryos 
transferred eSET§ (%)
No. of embryo 
transfer 
procedures
Average no. of 
embryos 
transferred eSET§ (%)
Alabama 297 1.8 16.4 98 2.1 6.6 79 2.7 0.0
Alaska 47 1.8 26.8 27 1.9 18.2 15 —¶ —¶
Arizona 331 1.8 24.5 148 2.1 6.7 178 2.3 2.7
Arkansas 136 1.8 14.8 40 2.0 2.9 27 2.0 0.0
California** 2,543 1.7 29.7 1,650 1.9 19.0 2,859 2.6 3.8
Colorado 200 1.8 22.6 79 2.0 8.6 50 2.3 4.9
Connecticut 731 1.6 32.1 348 1.8 14.1 563 2.3 1.9
Delaware 89 1.3 67.9 23 1.7 36.8 34 2.1 12.5
District of Columbia 110 1.4 60.4 107 1.6 35.4 261 2.1 8.2
Florida 1,477 1.7 23.7 715 1.9 9.1 1,031 2.3 2.5
Georgia** 697 1.6 35.5 306 1.9 11.5 345 2.4 3.0
Hawaii** 114 1.9 17.4 87 2.3 4.9 179 2.7 2.6
Idaho 120 1.9 13.4 46 2.1 2.4 30 2.0 12.5
Illinois 2,091 1.7 27.2 945 1.9 13.1 1,388 2.3 2.7
Indiana 620 1.9 10.4 189 2.0 9.0 175 2.2 2.1
Iowa 310 1.6 39.6 80 1.7 26.5 77 2.3 4.3
Kansas 239 1.7 23.3 61 2.0 3.6 53 2.1 2.1
Kentucky 372 1.9 18.3 132 1.9 8.3 106 2.3 1.1
Louisiana 293 1.9 11.2 69 2.0 4.8 97 2.2 6.2
Maine 91 1.4 58.7 46 1.5 39.5 60 2.0 8.3
Maryland 1,121 1.4 51.8 592 1.6 35.1 918 2.1 8.4
Massachusetts 1,930 1.4 51.5 1,137 1.6 32.1 1,952 2.5 7.0
Michigan 861 1.9 15.0 308 2.0 10.5 370 2.3 4.1
Minnesota 571 1.7 30.2 175 1.8 17.3 194 2.0 7.8
Mississippi 120 1.8 22.4 43 2.0 5.3 52 2.1 0.0
Missouri 601 1.8 13.5 183 2.0 6.3 154 2.6 0.0
Montana 70 1.6 36.9 16 —¶ —¶ 28 3.0 0.0
Nebraska 211 1.8 12.8 72 1.8 7.0 46 2.3 0.0
Nevada 191 1.7 24.4 73 1.7 16.9 92 1.9 10.0
New Hampshire 189 1.4 51.0 99 1.6 29.9 93 2.4 3.8
New Jersey 1,310 1.6 34.7 699 1.8 19.1 1,054 2.2 8.2
New Mexico 31 1.8 17.9 8 —¶ —¶ 13 —¶ —¶
New York 3,075 1.7 30.0 1,835 1.9 15.5 3,883 2.3 5.2
North Carolina 621 1.7 28.1 280 1.8 15.9 310 2.4 3.3
North Dakota 89 1.8 17.2 22 1.9 9.5 25 2.2 4.5
Ohio 1,087 1.9 14.9 442 2.0 6.5 393 2.4 2.9
Oklahoma 303 1.9 6.2 76 1.9 3.2 62 2.4 0.0
Oregon 248 1.9 15.2 123 1.8 15.8 89 2.2 9.0
Pennsylvania 1,357 1.7 33.9 629 1.9 16.6 743 2.3 5.9
Puerto Rico 74 2.1 4.3 48 2.2 4.7 59 2.4 0.0
Rhode Island 162 1.6 34.5 96 1.9 11.4 138 2.6 4.1
South Carolina 265 1.9 14.7 120 2.0 6.4 154 2.4 4.5
South Dakota 68 1.7 30.2 21 1.9 0 14 —¶ —¶
Tennessee 316 1.8 22.8 115 2.0 6.7 111 2.4 2.2
Texas 2,128 1.8 21.1 933 2.0 8.4 1,139 2.3 1.6
Utah 478 1.8 18.0 137 2.0 7.1 118 2.2 3.1
Vermont 50 1.7 21.4 34 1.8 19.4 33 2.3 3.2
Virginia 1,038 1.5 40.3 540 1.7 31.1 894 2.1 7.2
Washington 540 1.6 38.0 235 1.7 24.8 297 2.1 6.4
West Virginia 92 1.8 18.5 30 1.9 8.3 27 2.4 0.0
Wisconsin 429 1.7 27.1 134 1.8 18.5 125 2.2 4.6
Wyoming 37 1.8 13.9 11 —¶ —¶ 6 —¶ —¶
Nonresident 316 1.8 22.8 185 1.7 19.9 311 2.2 8.9
Total 30,887 1.7 28.5 14,647 1.9 16.7 21,504 2.3 4.7
Abbreviation: eSET = elective single-embryo transfer.
 * Includes all procedures in which at least one embryo was transferred.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the assisted reproductive technology procedure was performed.
 § A procedure in which one embryo, selected from a larger number of available embryos, is placed in the uterus. A cycle in which only one embryo is available is not defined as eSET.
 ¶ Estimates on the basis of N <20 in the denominator have been suppressed because such rates are considered unstable.
 ** In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency information was missing for 
963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
Surveillance Summaries
MMWR / February 10, 2017 / Vol. 66 / No. 6 17US Department of Health and Human Services/Centers for Disease Control and Prevention
TABLE 3. Number, proportion, and percentage of infants born with the use of assisted reproductive technology, by female patient’s reporting 
area of residence* at time of treatment — United States and Puerto Rico, 2014†
Patient’s reporting 
area of residence
Total no. of 
infants born§
No. of ART 
infants born
Proportion of 
ART infants 
among all 
infants (%)
Singleton infants 
among ART infants
Singleton infants 
among all infants§
Proportion of ART 
singleton infants 
among all 
singleton infants 
(%)No. (%) No. (%)
Alabama 59,422 466 0.8 231 (49.6) 57,307 (96.4) 0.4
Alaska 11,392 56 0.5 36 (64.3) 11,031 (96.8) 0.3
Arizona 86,887 1,030 1.2 616 (59.8) 84,240 (97.0) 0.7
Arkansas 38,511 196 0.5 118 (60.2) 37,358 (97.0) 0.3
California¶ 502,879 8,528 1.7 5,389 (63.2) 486,558 (96.8) 1.1
Colorado 65,830 993 1.5 580 (58.4) 63,748 (96.8) 0.9
Connecticut 36,285 1,321 3.6 829 (62.8) 34,715 (95.7) 2.4
Delaware 10,972 226 2.1 200 (88.5) 10,654 (97.1) 1.9
District of Columbia 9,509 361 3.8 283 (78.4) 9,153 (96.3) 3.1
Florida 219,991 2,900 1.3 1,641 (56.6) 212,467 (96.6) 0.8
Georgia¶ 130,946 1,487 1.1 886 (59.6) 126,403 (96.5) 0.7
Hawaii¶ 18,550 447 2.4 230 (51.5) 17,969 (96.9) 1.3
Idaho 22,876 218 1.0 116 (53.2) 22,186 (97.0) 0.5
Illinois 158,556 4,074 2.6 2,459 (60.4) 152,251 (96.0) 1.6
Indiana 84,080 814 1.0 431 (52.9) 81,163 (96.5) 0.5
Iowa 39,687 629 1.6 399 (63.4) 38,256 (96.4) 1.0
Kansas 39,223 361 0.9 216 (59.8) 37,964 (96.8) 0.6
Kentucky 56,170 508 0.9 247 (48.6) 54,304 (96.7) 0.5
Louisiana 64,497 542 0.8 284 (52.4) 62,124 (96.3) 0.5
Maine 12,698 146 1.1 95 (65.1) 12,224 (96.3) 0.8
Maryland 73,921 1,956 2.6 1,423 (72.8) 71,056 (96.1) 2.0
Massachusetts 71,908 3,413 4.7 2,302 (67.4) 68,839 (95.7) 3.3
Michigan 11,4375 1,503 1.3 830 (55.2) 110,146 (96.3) 0.8
Minnesota 69,904 1,172 1.7 689 (58.8) 67,312 (96.3) 1.0
Mississippi 38,736 248 0.6 145 (58.5) 37,390 (96.5) 0.4
Missouri 75,360 870 1.2 492 (56.6) 72,727 (96.5) 0.7
Montana 12,432 128 1.0 65 (50.8) 12,004 (96.6) 0.5
Nebraska 26,794 351 1.3 168 (47.9) 25,859 (96.5) 0.6
Nevada 35,861 559 1.6 332 (59.4) 34,726 (96.8) 1.0
New Hampshire 12,302 295 2.4 184 (62.4) 11,844 (96.3) 1.6
New Jersey 103,305 3,786 3.7 2,384 (63.0) 98,805 (95.6) 2.4
New Mexico 26,052 129 0.5 81 (62.8) 25,445 (97.7) 0.3
New York 238,773 6,492 2.7 4,175 (64.3) 229,570 (96.1) 1.8
North Carolina 120,975 1,559 1.3 898 (57.6) 116,626 (96.4) 0.8
North Dakota 11,359 142 1.3 77 (54.2) 10,977 (96.6) 0.7
Ohio 139,467 1,672 1.2 882 (52.8) 134,327 (96.3) 0.7
Oklahoma 53,339 419 0.8 213 (50.8) 51,681 (96.9) 0.4
Oregon 45,556 672 1.5 338 (50.3) 43,941 (96.5) 0.8
Pennsylvania 142,268 2,442 1.7 1,540 (63.1) 136,985 (96.3) 1.1
Puerto Rico 34,434 133 0.4 59 (44.4) 33,663 (97.8) 0.2
Rhode Island 10,823 232 2.1 147 (63.4) 10,453 (96.6) 1.4
South Carolina 57,627 548 1.0 309 (56.4) 55,548 (96.4) 0.6
South Dakota 12,283 126 1.0 68 (54.0) 11,882 (96.7) 0.6
Tennessee 81,602 634 0.8 362 (57.1) 78,919 (96.7) 0.5
Texas 399,766 5,268 1.3 2,892 (54.9) 386,674 (96.7) 0.7
Utah 51,154 730 1.4 349 (47.8) 49,287 (96.4) 0.7
Vermont 6,130 107 1.7 56 (52.3) 5,874 (95.8) 1.0
Virginia 103,300 2,163 2.1 1,467 (67.8) 99,469 (96.3) 1.5
Washington 88,585 1,299 1.5 808 (62.2) 85,847 (96.9) 0.9
West Virginia 20,301 101 0.5 64 (63.4) 19,623 (96.7) 0.3
Wisconsin 67,161 790 1.2 464 (58.7) 64,864 (96.6) 0.7
Wyoming 7,696 54 0.7 33 (61.1) 7,439 (96.7) 0.4
Total 4,022,510 65,296 1.6 39,582 (60.6) 3,881,877 (96.5) 1.0
Abbreviation: ART = assisted reproductive technology.
* In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
† Includes infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 and born in 
2014. Total ART births exclude nonresidents.
§ U.S. births include nonresidents (24).
¶ In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency information 
was missing for 963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
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TABLE 4. Number, percentage, and proportion of multiple-birth, twins, and triplets and higher-order infants born with use of assisted reproductive technol-
ogy procedure, by female patient’s reporting area of residence* at time of treatment — United States and Puerto Rico, 2014†
Patient’s reporting 
area of residence
Multiple-birth 
infants among 
ART infants§
No. (%)
Multiple-birth 
infants among 
all infants¶
No. (%)
Proportion of 
ART multiple-
birth infants 
among all 
multiple-birth 
infants (%)
Twin infants 
among ART 
infants§
No. (%)
Twin infants 
among all 
infants¶
No. (%)
Proportion of 
ART twin 
infants among 
all twin infants 
(%)
Triplets and 
higher-order 
infants among 
ART infants§
No. (%)
Triplets and 
higher-order 
infants among 
all infants¶
No. (%)
Proportion of ART 
triplets and 
higher-order 
infants among all 
triplets and 
higher-order 
infants (%)
Alabama 235 (50.4) 2,115 (3.6) 11.1 229 (49.1) 2,072 (3.5) 11.1 6 (1.3) 43 (0.1) 14.0
Alaska 20 (35.7) 361 (3.2) 5.5 20 (35.7) — (—)** —** 0 (0.0) — (—)** 0.0
Arizona 414 (40.2) 2,647 (3.0) 15.6 392 (38.1) 2,579 (3.0) 15.2 22 (2.1) 68 (0.1) 32.4
Arkansas 78 (39.8) 1,153 (3.0) 6.8 72 (36.7) 1,110 (2.9) 6.5 6 (3.1) 43 (0.1) 14.0
California¶¶ 3,139 (36.8) 16,321 (3.2) 19.2 2,976 (34.9) 15,832 (3.1) 18.8 163 (1.9) 489 (0.1) 33.3
Colorado 413 (41.6) 2,082 (3.2) 19.8 392 (39.5) 2,019 (3.1) 19.4 21 (2.1) 63 (0.1) 33.3
Connecticut 492 (37.2) 1,570 (4.3) 31.3 474 (35.9) 1,525 (4.2) 31.1 18 (1.4) 45 (0.1) 40.0
Delaware 26 (11.5) 318 (2.9) 8.2 26 (11.5) — (—)** —** 0 (0.0) — (—)** 0.0
District of Columbia 78 (21.6) 356 (3.7) 21.9 72 (19.9) 344 (3.6) 20.9 6 (1.7) 12 (0.1) —††
Florida 1,259 (43.4) 7,524 (3.4) 16.7 1,190 (41.0) 7,307 (3.3) 16.3 69 (2.4) 217 (0.1) 31.8
Georgia¶¶ 601 (40.4) 4,543 (3.5) 13.2 571 (38.4) 4,411 (3.4) 12.9 30 (2.0) 132 (0.1) 22.7
Hawaii¶¶ 217 (48.5) 581 (3.1) 37.3 202 (45.2) 558 (3.0) 36.2 15 (3.4) 23 (0.1) 65.2
Idaho 102 (46.8) 690 (3.0) 14.8 — (—)** 678 (3.0) —** — (—)** 12 (0.1) —**,††
Illinois 1,615 (39.6) 6,305 (4.0) 25.6 1,552 (38.1) 6,085 (3.8) 25.5 63 (1.5) 220 (0.1) 28.6
Indiana 383 (47.1) 2,917 (3.5) 13.1 359 (44.1) 2,799 (3.3) 12.8 24 (2.9) 118 (0.1) 20.3
Iowa 230 (36.6) 1,431 (3.6) 16.1 — (—)** 1,365 (3.4) —** — (—)** 66 (0.2) —**
Kansas 145 (40.2) 1,259 (3.2) 11.5 130 (36.0) 1,213 (3.1) 10.7 15 (4.2) 46 (0.1) 32.6
Kentucky 261 (51.4) 1,866 (3.3) 14.0 234 (46.1) 1,794 (3.2) 13.0 27 (5.3) 72 (0.1) 37.5
Louisiana 258 (47.6) 2,373 (3.7) 10.9 246 (45.4) 2,295 (3.6) 10.7 12 (2.2) 78 (0.1) 15.4
Maine 51 (34.9) 474 (3.7) 10.8 — (—)** 453 (3.6) —** — (—)** 21 (0.2) —**
Maryland 533 (27.2) 2,865 (3.9) 18.6 516 (26.4) 2,783 (3.8) 18.5 17 (0.9) 82 (0.1) 20.7
Massachusetts 1,111 (32.6) 3,069 (4.3) 36.2 1,066 (31.2) 2,986 (4.2) 35.7 45 (1.3) 83 (0.1) 54.2
Michigan 673 (44.8) 4,229 (3.7) 15.9 643 (42.8) 4,100 (3.6) 15.7 30 (2.0) 129 (0.1) 23.3
Minnesota 483 (41.2) 2,592 (3.7) 18.6 469 (40.0) 2,535 (3.6) 18.5 14 (1.2) 57 (0.1) 24.6
Mississippi 103 (41.5) 1,346 (3.5) 7.7 97 (39.1) 1,316 (3.4) 7.4 6 (2.4) 30 (0.1) 20.0
Missouri 378 (43.4) 2,633 (3.5) 14.4 363 (41.7) 2,567 (3.4) 14.1 15 (1.7) 66 (0.1) 22.7
Montana 63 (49.2) 428 (3.4) 14.7 63 (49.2) 420 (3.4) 15.0 0 (0.0) 8 (0.1) 0.0
Nebraska 183 (52.1) 935 (3.5) 19.6 168 (47.9) 878 (3.3) 19.1 15 (4.3) 57 (0.2) 26.3
Nevada 227 (40.6) 1,135 (3.2) 20.0 — (—)** 1,109 (3.1) —** — (—)** 26 (0.1) —**
New Hampshire 111 (37.6) 458 (3.7) 24.2 — (—)** 452 (3.7) —** — (—)** 6 (0.0) —**,††
New Jersey 1,402 (37.0) 4,500 (4.4) 31.2 1,360 (35.9) 4,343 (4.2) 31.3 42 (1.1) 157 (0.2) 26.8
New Mexico 48 (37.2) 607 (2.3) 7.9 42 (32.6) 580 (2.2) 7.2 6 (4.7) 27 (0.1) 22.2
New York 2,317 (35.7) 9,203 (3.9) 25.2 2,198 (33.9) 8,840 (3.7) 24.9 119 (1.8) 363 (0.2) 32.8
North Carolina 661 (42.4) 4,349 (3.6) 15.2 643 (41.2) 4,233 (3.5) 15.2 18 (1.2) 116 (0.1) 15.5
North Dakota 65 (45.8) 382 (3.4) 17.0 — (—)** 360 (3.2) —** — (—)** 22 (0.2) —**
Ohio 790 (47.2) 5,140 (3.7) 15.4 741 (44.3) 4,904 (3.5) 15.1 49 (2.9) 236 (0.2) 20.8
Oklahoma 206 (49.2) 1,658 (3.1) 12.4 189 (45.1) 1,582 (3.0) 11.9 17 (4.1) 76 (0.1) 22.4
Oregon 334 (49.6) 1,615 (3.5) 20.7 328 (48.7) 1,572 (3.5) 20.9 6 (0.9) 43 (0.1) 14.0
Pennsylvania 902 (36.9) 5,283 (3.7) 17.1 875 (35.8) 5,158 (3.6) 17.0 27 (1.1) 125 (0.1) 21.6
Puerto Rico 74 (55.6) 771 (2.2) 9.6 68 (51.1) 750 (2.2) 9.1 6 (4.5) 21 (0.1) 28.6
Rhode Island 85 (36.6) 370 (3.4) 23.0 — (—)** 358 (3.3) —** — (—)** 12 (0.1) —**,††
South Carolina 239 (43.6) 2,079 (3.6) 11.5 — (—)** 2,030 (3.5) —** — (—)** 49 (0.1) —**
South Dakota 58 (46.0) 401 (3.3) 14.5 52 (41.3) 389 (3.2) 13.4 6 (4.8) 12 (0.1) —††
Tennessee 272 (42.9) 2,683 (3.3) 10.1 258 (40.7) 2,596 (3.2) 9.9 14 (2.2) 87 (0.1) 16.1
Texas 2,376 (45.1) 13,092 (3.3) 18.1 2,238 (42.5) 12,600 (3.2) 17.8 138 (2.6) 492 (0.1) 28.0
Utah 381 (52.2) 1,867 (3.6) 20.4 365 (50.0) 1,797 (3.5) 20.3 16 (2.2) 70 (0.1) 22.9
Vermont 51 (47.7) 256 (4.2) 19.9 — (—)** 250 (4.1) —** — (—)** 6 (0.1) —**,††
Virginia 696 (32.2) 3,831 (3.7) 18.2 662 (30.6) 3,682 (3.6) 18.0 34 (1.6) 149 (0.1) 22.8
Washington 491 (37.7) 2,738 (3.1) 17.9 470 (36.0) 2,660 (3.0) 17.7 21 (1.6) 78 (0.1) 26.9
West Virginia 37 (36.6) 678 (3.3) 5.5 — (—)** 657 (3.2) —** — (—)** 21 (0.1) —**
Wisconsin 326 (41.3) 2,297 (3.4) 14.2 317 (40.1) 2,236 (3.3) 14.2 9 (1.1) 61 (0.1) 14.8
Wyoming 21 (38.9) 257 (3.3) 8.2 — (—)** 251 (3.3) —** — (—)** 6 (0.1) —**,††
Total 25,714 (39.4) 140,633 (3.5) 18.3 24,514 (37.5) 136,086 (3.4) 18.0 1,200 (1.8) 4,547 (0.1) 26.4
Abbreviation: ART = assisted reproductive technology.
 * In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 † ART totals include infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 and born in 2014. Total 
ART births exclude nonresidents.
 § Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants was stillborn, the total 
number of live-born infants would be two. However, the two infants still would be counted as triplets.
 ¶ U.S. births include nonresidents (24).
 ** To protect confidentiality, cells with values from 1–4 are suppressed, as are data that can be used to derive cell values of 1–4. These values are included in totals.
 †† Estimates on the basis of N <20 in the denominator have been suppressed because such rates are considered unstable.
 ¶¶ In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency information was missing for 
963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
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TABLE 5. Number, percentage, and proportion of infants born with use of assisted reproductive technology,* by low birthweight category and 
female patient’s reporting area of residence† at time of treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
<2,500 g (LBW) <1,500 g (VLBW)
ART infants 
No. (%)
All infants§ 
No. (%)
Proportion of ART 
LBW infants among 
all LBW infants (%)
ART infants 
No. (%)
All infants§ 
No. (%)
Proportion of ART 
VLBW infants among 
all VLBW infants (%)
Alabama 162 (35.2) 5,989 (10.1) 2.7 25 (5.4) 1,135 (1.9) 2.2
Alaska 16 (29.6) 672 (5.9) 2.4 — (—)¶ 101 (0.9) —¶
Arizona 283 (28.3) 6,086 (7.0) 4.7 55 (5.5) 1,004 (1.2) 5.5
Arkansas 61 (31.1) 3,432 (8.9) 1.8 11 (5.6) 558 (1.4) 2.0
California** 2,091 (25.2) 33,586 (6.7) 6.2 360 (4.3) 5,727 (1.1) 6.3
Colorado 334 (34.2) 5,769 (8.8) 5.8 45 (4.6) 799 (1.2) 5.6
Connecticut 325 (24.8) 2,763 (7.6) 11.8 67 (5.1) 499 (1.4) 13.4
Delaware 24 (10.6) 908 (8.3) 2.6 8 (3.5) 194 (1.8) 4.1
District of Columbia 59 (16.4) 934 (9.8) 6.3 8 (2.2) 198 (2.1) 4.0
Florida 831 (29.4) 19,065 (8.7) 4.4 160 (5.7) 3,501 (1.6) 4.6
Georgia** 445 (30.2) 12,385 (9.5) 3.6 87 (5.9) 2,321 (1.8) 3.7
Hawaii** 165 (38.6) 1,462 (7.9) 11.3 34 (7.9) 243 (1.3) 14.0
Idaho 74 (33.9) 1,471 (6.4) 5.0 — (—)¶ 227 (1.0) —¶
Illinois 1,119 (27.7) 12,929 (8.2) 8.7 186 (4.6) 2,409 (1.5) 7.7
Indiana 242 (29.8) 6,715 (8.0) 3.6 39 (4.8) 1,146 (1.4) 3.4
Iowa 156 (24.8) 2,675 (6.7) 5.8 24 (3.8) 460 (1.2) 5.2
Kansas 108 (30.5) 2,759 (7.0) 3.9 17 (4.8) 493 (1.3) 3.4
Kentucky 179 (35.9) 4,922 (8.8) 3.6 42 (8.4) 819 (1.5) 5.1
Louisiana 195 (36.0) 6,786 (10.5) 2.9 52 (9.6) 1,230 (1.9) 4.2
Maine 34 (23.6) 960 (7.6) 3.5 7 (4.9) 157 (1.2) 4.5
Maryland 471 (24.2) 6,345 (8.6) 7.4 78 (4.0) 1,186 (1.6) 6.6
Massachusetts 761 (22.6) 5,351 (7.4) 14.2 113 (3.4) 860 (1.2) 13.1
Michigan 458 (30.6) 9,545 (8.3) 4.8 89 (5.9) 1,688 (1.5) 5.3
Minnesota 308 (26.5) 4,595 (6.6) 6.7 56 (4.8) 790 (1.1) 7.1
Mississippi 69 (28.3) 4,374 (11.3) 1.6 13 (5.3) 804 (2.1) 1.6
Missouri 259 (30.9) 6,163 (8.2) 4.2 43 (5.1) 1,022 (1.4) 4.2
Montana 45 (35.4) 920 (7.4) 4.9 12 (9.4) 152 (1.2) 7.9
Nebraska 109 (31.2) 1,775 (6.6) 6.1 18 (5.2) 312 (1.2) 5.8
Nevada 154 (28.5) 2,972 (8.3) 5.2 20 (3.7) 509 (1.4) 3.9
New Hampshire 82 (28.0) 852 (6.9) 9.6 16 (5.5) 130 (1.1) 12.3
New Jersey 1,013 (26.9) 8,315 (8.0) 12.2 178 (4.7) 1,519 (1.5) 11.7
New Mexico 40 (31.3) 2,282 (8.8) 1.8 12 (9.4) 349 (1.3) 3.4
New York 1,676 (27.0) 18,722 (7.8) 9.0 304 (4.9) 3,298 (1.4) 9.2
North Carolina 425 (27.3) 10,720 (8.9) 4.0 68 (4.4) 1,997 (1.7) 3.4
North Dakota 43 (30.3) 704 (6.2) 6.1 13 (9.2) 116 (1.0) 11.2
Ohio 531 (31.9) 11,800 (8.5) 4.5 100 (6.0) 2,185 (1.6) 4.6
Oklahoma 143 (34.1) 4,238 (7.9) 3.4 24 (5.7) 766 (1.4) 3.1
Oregon 191 (28.6) 2,842 (6.2) 6.7 23 (3.4) 455 (1.0) 5.1
Pennsylvania 628 (25.8) 11,713 (8.2) 5.4 100 (4.1) 2,006 (1.4) 5.0
Puerto Rico 59 (44.4) 3,713 (10.8) 1.6 11 (8.3) 502 (1.5) 2.2
Rhode Island 47 (20.4) 765 (7.1) 6.1 11 (4.8) 150 (1.4) 7.3
South Carolina 165 (30.5) 5,435 (9.4) 3.0 32 (5.9) 1,016 (1.8) 3.1
South Dakota 33 (26.2) 804 (6.5) 4.1 5 (4.0) 125 (1.0) 4.0
Tennessee 202 (31.9) 7,297 (8.9) 2.8 39 (6.2) 1,260 (1.5) 3.1
Texas 1,729 (33.3) 32,744 (8.2) 5.3 353 (6.8) 5,722 (1.4) 6.2
Utah 261 (36.0) 3,572 (7.0) 7.3 37 (5.1) 552 (1.1) 6.7
Vermont 35 (33.3) 432 (7.0) 8.1 9 (8.6) 65 (1.1) 13.8
Virginia 497 (23.2) 8,130 (7.9) 6.1 89 (4.2) 1,547 (1.5) 5.8
Washington 302 (23.4) 5,705 (6.4) 5.3 31 (2.4) 888 (1.0) 3.5
West Virginia 23 (23.2) 1,852 (9.1) 1.2 5 (5.1) 278 (1.4) 1.8
Wisconsin 198 (25.3) 4,911 (7.3) 4.0 38 (4.9) 876 (1.3) 4.3
Wyoming 15 (27.8) 704 (9.1) 2.1 — (—)¶ 103 (1.3) —¶
Total 17,875 (27.8) 322,560 (8.0) 5.5 3,174 (4.9) 56,449 (1.4) 5.6
Abbreviations: ART = assisted reproductive technology; LBW = low birthweight; VLBW = very low birthweight.
 * ART totals include infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 
and born in 2014. Total ART infants exclude nonresidents and include only infants with birthweight data available.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 § U.S. births include nonresidents (24).
 ¶ To protect confidentiality, cells with values from 1–4 are suppressed, as are data that can be used to derive cell values of 1–4. These values are included in totals.
 ** In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency 
information was missing for 963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
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TABLE 6. Number, percentage, and proportion of infants born with use of assisted reproductive technology,* by preterm gestational age 
category and female patient’s reporting area of residence† at time of treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
<37 weeks (PTB) <32 weeks (VPTB)
ART infants
No. (%)
All infants§
No. (%)
Proportion of ART 
PTB infants among 
all PTB infants (%)
ART infants
No. (%)
All infants§
No. (%)
Proportion of ART 
VPTB infants among 
all VPTB infants (%)
Alabama 190 (41.2) 9,051 (15.2) 2.1 35 (7.6) 1,719 (2.9) 2.0
Alaska 20 (35.7) 1,148 (10.1) 1.7 6 (10.7) 158 (1.4) 3.8
Arizona 367 (35.7) 10,100 (11.6) 3.6 59 (5.7) 1,595 (1.8) 3.7
Arkansas 73 (37.2) 4,857 (12.6) 1.5 12 (6.1) 743 (1.9) 1.6
California¶ 2,490 (29.4) 42,672 (8.5) 5.8 458 (5.4) 6,621 (1.3) 6.9
Colorado 353 (36.0) 6,627 (10.1) 5.3 50 (5.1) 1,022 (1.6) 4.9
Connecticut 390 (29.7) 3,410 (9.4) 11.4 70 (5.3) 600 (1.7) 11.7
Delaware 43 (19.1) 1,389 (12.7) 3.1 9 (4.0) 310 (2.8) 2.9
District of Columbia 68 (18.9) 1,269 (13.3) 5.4 8 (2.2) 247 (2.6) 3.2
Florida 1,018 (35.3) 28,724 (13.1) 3.5 204 (7.1) 5,024 (2.3) 4.1
Georgia¶ 557 (37.8) 16,504 (12.6) 3.4 98 (6.6) 3,003 (2.3) 3.3
Hawaii¶ 175 (39.2) 2,236 (12.1) 7.8 40 (9.0) 350 (1.9) 11.4
Idaho 83 (38.1) 2,239 (9.8) 3.7 8 (3.7) 298 (1.3) 2.7
Illinois 1361 (33.5) 18,760 (11.8) 7.3 248 (6.1) 3,438 (2.2) 7.2
Indiana 305 (37.5) 9,233 (11.0) 3.3 43 (5.3) 1,492 (1.8) 2.9
Iowa 208 (33.1) 4,471 (11.3) 4.7 38 (6.0) 779 (2.0) 4.9
Kansas 136 (37.8) 4,279 (10.9) 3.2 25 (6.9) 635 (1.6) 3.9
Kentucky 216 (42.7) 7,079 (12.6) 3.1 46 (9.1) 1,169 (2.1) 3.9
Louisiana 244 (45.1) 9,793 (15.2) 2.5 57 (10.5) 1,730 (2.7) 3.3
Maine 45 (30.8) 1,151 (9.1) 3.9 8 (5.5) 173 (1.4) 4.6
Maryland 520 (26.6) 9,051 (12.2) 5.7 102 (5.2) 1,620 (2.2) 6.3
Massachusetts 945 (27.8) 7,033 (9.8) 13.4 163 (4.8) 1,112 (1.5) 14.7
Michigan 587 (39.2) 13,547 (11.8) 4.3 103 (6.9) 2,401 (2.1) 4.3
Minnesota 372 (31.8) 7,000 (10.0) 5.3 60 (5.1) 1,161 (1.7) 5.2
Mississippi 108 (43.7) 6,193 (16.0) 1.7 19 (7.7) 1,085 (2.8) 1.8
Missouri 305 (35.1) 8,836 (11.7) 3.5 48 (5.5) 1,409 (1.9) 3.4
Montana 50 (39.1) 1,426 (11.5) 3.5 13 (10.2) 227 (1.8) 5.7
Nebraska 153 (43.7) 2,852 (10.6) 5.4 29 (8.3) 482 (1.8) 6.0
Nevada 214 (38.7) 4,678 (13.0) 4.6 32 (5.8) 730 (2.0) 4.4
New Hampshire 87 (29.5) 1,116 (9.1) 7.8 19 (6.4) 180 (1.5) 10.6
New Jersey 1,208 (32.1) 11,718 (11.3) 10.3 204 (5.4) 2,000 (1.9) 10.2
New Mexico 45 (34.9) 2,975 (11.4) 1.5 11 (8.5) 410 (1.6) 2.7
New York 1,918 (29.7) 25,398 (10.6) 7.6 335 (5.2) 4,023 (1.7) 8.3
North Carolina 516 (33.3) 14,550 (12.0) 3.5 81 (5.2) 2,929 (2.4) 2.8
North Dakota 55 (38.7) 1,126 (9.9) 4.9 17 (12.0) 182 (1.6) 9.3
Ohio 601 (36.1) 16,755 (12.0) 3.6 102 (6.1) 3,116 (2.2) 3.3
Oklahoma 172 (41.1) 6,881 (12.9) 2.5 33 (7.9) 1,098 (2.1) 3.0
Oregon 239 (35.7) 4,228 (9.3) 5.7 37 (5.5) 624 (1.4) 5.9
Pennsylvania 661 (27.1) 15,015 (10.6) 4.4 121 (5.0) 2,684 (1.9) 4.5
Puerto Rico 61 (45.9) 5,223 (15.2) 1.2 9 (6.8) 819 (2.4) —**
Rhode Island 56 (24.1) 1,107 (10.2) 5.1 9 (3.9) 193 (1.8) 4.7
South Carolina 222 (40.7) 7,765 (13.5) 2.9 39 (7.1) 1,432 (2.5) 2.7
South Dakota 46 (36.5) 1,346 (11.0) 3.4 7 (5.6) 192 (1.6) 3.6
Tennessee 254 (40.1) 10,221 (12.5) 2.5 43 (6.8) 1,593 (2.0) 2.7
Texas 2,206 (42.1) 49,527 (12.4) 4.5 431 (8.2) 7,738 (1.9) 5.6
Utah 280 (38.8) 5,196 (10.2) 5.4 42 (5.8) 668 (1.3) 6.3
Vermont 40 (37.4) 527 (8.6) 7.6 7 (6.5) 95 (1.5) 7.4
Virginia 598 (27.8) 11,098 (10.7) 5.4 101 (4.7) 2,017 (2.0) 5.0
Washington 360 (27.8) 8,505 (9.6) 4.2 42 (3.2) 1,297 (1.5) 3.2
West Virginia 38 (37.6) 2,683 (13.2) 1.4 — (—)** 449 (2.2) —**
Wisconsin 273 (34.7) 6,854 (10.2) 4.0 57 (7.2) 1,119 (1.7) 5.1
Wyoming 14 (25.9) 885 (11.5) 1.6 — (—)** 141 (1.8) —**
Total 21,546 (33.2) 456,307 (11.3) 4.7 3,846 (5.9) 76,332 (1.9) 5.0
Abbreviations: ART = assisted reproductive technology; PTB = preterm birth; VPTB = very preterm birth.
 * ART totals include infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 
and born in 2014. Total ART births exclude nonresidents and include only infants with gestational age data available.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 § U.S. births include nonresidents (24).
 ¶ In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency 
information was missing for 963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
 ** To protect confidentiality, cells with values from 1–4 are suppressed, as are data that can be used to derive cell values of 1–4. These values are included in totals.
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TABLE 7. Percentages of low birthweight infants (<2,500 g) among infants born with assisted reproductive technology* and all U.S. infants, 
by plurality and female patient’s reporting area of residence† at time of treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
ART singleton infants 
(%)
All singleton infants§ 
(%)
ART twin infants¶ 
(%)
All twin infants§ 
(%)
ART triplets and 
higher-order infants¶ 
(%)
All triplets and 
higher-order infants§ 
(%)
Alabama 9.6 8.1 59.6 62.2 —** 88.4
Alaska —†† 4.6 77.8 46.1 —§§ —**
Arizona 9.9 5.5 53.2 53.5 100.0 91.2
Arkansas 10.2 7.3 59.7 59.3 —** 100.0
California¶¶ 8.0 5.1 52.9 51.4 94.4 94.1
Colorado 11.2 7.1 64.8 59.7 100.0 96.8
Connecticut 8.2 5.6 51.2 52.0 —** 100.0
Delaware 7.0 7.0 38.5 49.8 —§§ —**
District of Columbia 8.5 7.9 40.3 57.0 —** —**
Florida 10.4 6.9 52.1 57.2 93.7 95.4
Georgia¶¶ 9.9 7.6 58.6 60.0 90.0 94.7
Hawaii¶¶ 10.9 6.2 65.6 59.9 —** 100.0
Idaho 7.8 5.0 62.6 53.3 —**,†† —**
Illinois 9.1 6.1 54.4 55.5 98.4 100.0
Indiana 6.0 6.2 54.0 55.2 91.7 100.0
Iowa 6.8 5.0 55.5 51.0 —**,†† 100.0
Kansas 6.6 5.5 62.5 52.5 —** 100.0
Kentucky 9.1 7.1 56.5 56.6 100.0 100.0
Louisiana 9.5 8.4 63.4 64.9 —** 100.0
Maine —†† 5.6 58.3 57.3 —**,†† —††
Maryland 10.9 6.7 58.4 55.1 —** 93.9
Massachusetts 8.5 5.3 50.6 54.0 95.2 94.0
Michigan 9.9 6.5 54.1 54.5 100.0 100.0
Minnesota 8.1 4.9 51.0 48.8 —** 100.0
Mississippi 10.5 9.3 50.5 65.6 —** 100.0
Missouri 8.7 6.3 58.3 57.8 —** 100.0
Montana 10.8 5.8 61.3 51.7 —§§ —**
Nebraska 6.0 5.0 50.6 50.3 —** 100.0
Nevada 10.3 6.6 54.4 58.8 —**,†† —††
New Hampshire 10.4 5.2 55.6 52.3 —**,†† —**
New Jersey 8.5 5.8 57.2 55.7 100.0 92.4
New Mexico 11.3 7.4 59.5 62.9 —** —††
New York 9.0 5.9 58.0 54.6 88.7 93.3
North Carolina 9.0 7.1 50.9 54.2 —** 94.8
North Dakota 7.8 4.6 54.8 50.0 —**,†† —††
Ohio 8.9 6.6 55.0 56.0 98.0 95.3
Oklahoma 8.9 6.4 56.6 54.9 —** 100.0
Oregon 8.3 4.6 48.3 48.7 —** 100.0
Pennsylvania 8.0 6.5 54.9 52.4 100.0 92.8
Puerto Rico 15.3 9.5 64.7 65.3 —** 95.2
Rhode Island 6.9 5.5 41.5 49.4 —**,†† —**,††
South Carolina 10.1 7.6 57.8 59.0 —** 100.0
South Dakota —†† 5.0 44.2 50.1 —** —**
Tennessee 9.7 7.2 59.3 60.1 —** 100.0
Texas 10.2 6.5 59.7 57.5 93.5 98.0
Utah 9.2 5.2 58.5 51.3 —** 100.0
Vermont 16.1 5.3 50.0 46.4 —**,†† —**
Virginia 8.9 6.1 51.1 52.0 100.0 100.0
Washington 7.9 5.0 46.8 51.3 90.5 88.5
West Virginia 7.8 7.2 53.1 62.9 —**,†† —††
Wisconsin 5.2 5.7 53.7 53.0 —** 100.0
Wyoming —†† 7.3 —** 61.0 —**,†† —**
Total 8.9 6.3 55.2 55.2 95.3 94.5
See table footnotes on the next page.
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Abbreviation: ART = assisted reproductive technology.
 * ART totals include infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 
and born in 2014. Total ART births exclude nonresidents and only include infants with birthweight data available.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 § U.S. births include nonresidents (24).
 ¶ Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants 
was stillborn, the total number of live-born infants would be two. However, the two infants still would be counted as triplets.
 ** Estimates on the basis of N <20 in the denominator have been suppressed because such rates are considered unstable.
 †† To protect confidentiality, cells with values from 1–4 are suppressed, as are data that can be used to derive cell values of 1–4. These values are included in totals. 
For all births, cell values are suppressed for cell/numerator <10 or if a total/subtotal for a range of cells with a single suppressed member.
 §§ Estimates not calculated because N = 0 for the denominator.
 ¶¶ In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency 
information was missing for 963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
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TABLE 8. Percentages of preterm (<37 weeks) infants among infants born with the use of assisted reproductive technology* and all U.S. infants, 
by plurality and female patient’s reporting area of residence† at time of treatment — United States and Puerto Rico, 2014
Patient’s reporting 
area of residence
ART singleton 
infants (%)
All singleton 
infants§ (%)
ART twin infants¶ 
(%)
All twin infants§ 
(%)
ART triplets and 
higher-order 
infants¶ (%)
All triplets and 
higher order-infants§ 
(%)
Alabama 14.5 13.5 66.5 62.4 —** 100.0
Alaska —†† 8.6 80.0 55.9 —§§ —**
Arizona 14.8 10.1 64.8 58.6 100.0 94.1
Arkansas 13.6 11.2 75.0 57.4 —**,†† 76.7
California¶¶ 12.1 7.0 56.9 52.3 98.2 94.9
Colorado 15.6 8.5 63.0 57.4 100.0 88.9
Connecticut 11.9 7.5 58.1 50.6 —** 71.1
Delaware 13.6 11.4 61.5 54.0 —§§ —**
District Of Columbia 9.9 1.7 —†† 52.9 —** —**
Florida 14.9 11.5 59.6 56.6 100.0 93.1
Georgia¶¶ 14.9 10.9 70.2 58.0 100.0 90.9
Hawaii¶¶ 13.1 10.6 64.4 54.8 —** 52.2
Idaho 12.9 8.2 65.7 60.9 —**,†† —**
Illinois 13.9 9.8 62.0 59.4 100.0 96.8
Indiana 11.2 9.3 64.9 56.9 100.0 100.0
Iowa 11.0 9.4 70.9 59.3 —**,†† 100.0
Kansas 11.6 9.3 73.8 58.3 —** 87.0
Kentucky 11.4 11.0 68.8 58.7 100.0 100.0
Louisiana 17.7 13.2 74.0 66.7 —** 93.6
Maine 12.6 7.3 62.5 53.4 —**,†† 93.6
Maryland 13.5 10.4 60.5 57.7 —** 100.0
Massachusetts 11.9 7.6 59.3 58.3 93.3 96.4
Michigan 16.7 10.1 65.6 57.2 100.0 89.9
Minnesota 11.6 8.3 59.3 52.3 —** 100.0
Mississippi 16.0 14.2 81.4 65.5 —** 66.7
Missouri 13.3 9.9 62.0 62.1 —** 98.5
Montana 10.8 9.9 68.3 55.3 —§§ —**
Nebraska 9.6 8.9 72.6 58.2 —** 87.7
Nevada 15.4 11.5 73.4 60.3 —**,†† 92.3
New Hampshire 10.9 7.4 59.3 52.0 —**,†† —**
New Jersey 12.6 9.3 63.9 54.8 100.0 95.5
New Mexico 14.8 10.2 71.4 59.7 —**,†† 100.0
New York 12.7 8.9 58.6 53.3 92.4 92.0
North Carolina 14.2 10.5 58.2 52.9 —** 89.7
North Dakota 10.4 8.3 71.0 55.0 —**,†† 68.2
Ohio 13.0 10.2 59.3 57.2 100.0 89.8
Oklahoma 13.1 11.3 67.2 61.4 —** 93.4
Oregon 16.3 7.6 54.3 52.6 —** 93.0
Pennsylvania 10.5 8.8 53.9 55.1 100.0 74.8
Puerto Rico 18.6 14.1 64.7 62.3 —** 100.0
Rhode Island 7.5 8.7 —†† 52.0 —**,†† —**
South Carolina 17.3 11.8 70.3 57.7 —**,†† 100.0
South Dakota 11.8 9.4 61.5 55.5 —** —**
Tennessee 15.5 10.8 71.3 61.1 —** 93.1
Texas 17.2 10.7 70.7 59.9 100.0 94.5
Utah 12.4 8.3 61.9 56.3 —** 100.0
Vermont 12.5 6.9 62.5 47.2 —**,†† —**
Virginia 11.0 9.1 61.2 52.6 100.0 91.3
Washington 10.5 8.2 54.3 52.3 100.0 80.8
West Virginia 23.4 11.4 58.8 64.2 —**,†† 57.1
Wisconsin 11.4 8.6 67.0 54.6 —** 96.7
Wyoming 15.2 9.6 —†† 66.9 —**,†† —**
Total 13.2 9.7 62.2 56.6 98.2 93.8
See table footnotes on the next page.
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Abbreviation: ART = assisted reproductive technology.
 * ART totals include infants conceived from ART procedures performed in 2013 and born in 2014 and infants conceived from ART procedures performed in 2014 
and born in 2014. Total ART births exclude nonresidents and includes only infants with gestational age data available.
 † In cases of missing residency data (0.6%), the patient’s residence was assigned as the location in which the ART procedure was performed.
 § U.S. births include nonresidents (24).
 ¶ Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants 
was stillborn, the total number of live-born infants would be two. However, the two infants still would be counted as triplets.
 ** Estimates on the basis of N <20 in the denominator have been suppressed because such rates are considered unstable.
 †† To protect confidentiality, cells with values from 1–4 are suppressed, as are data that can be used to derive cell values of 1–4. These values are included in totals.
 §§ Estimates not calculated because N = 0 for the denominator.
 ¶¶ In three states, >2% of residency information was missing for procedures performed: California (2.7%), Georgia (2.1%), and Hawaii (2.1%). Overall, residency 
information was missing for 963 (0.6%) procedures performed and 366 (0.7%) live-birth deliveries.
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